Global biodosimetry laboratories network for radiation emergencies

BDN Presentation



The World Health Organization (WHO) held a consultation meeting at WHO Headquarters, Geneva, Switzerland, December 17–18, 2007, to develop the framework for a global biodosimetry network. The WHO network is envisioned to enable dose assessment using multiple methods [cytogenetics, electron paramagnetic resonance (EPR), genomics, etc.]; however, the initial discussion focused on the cytogenetic bioassay (i.e., metaphase-spread dicentric assay). Few regional cytogenetic biodosimetry networks have been established so far. The roles and resources available from United Nations (UN) agencies that provide international cooperation in biological dosimetry after radiological emergencies were reviewed. In addition, extensive reliance on the use of the relevant International Standards Organization (ISO) standards was emphasized. The results of a WHO survey of global cytogenetic biological dosimetry capability were reported, and while the survey indicates robust global capability, there was also a clear lack of global leadership and coordination. The expert group, which had a concentrated focus on cytogenetic biodosimetry, formulated the general scope and concept of operations for the development of a WHO global biodosimetry laboratory network for radiation emergencies (BioDoseNet). Follow-on meetings were and are currently organized to further develop technical details for this network.

http://www.who.int/ionizing_radiation/a_e/biodosenet/en/index.html

 
The Global biodosimetry laboratories network for radiation emergencies, BioDoseNet, is a network initiative which development and set-up are investigated with WHO (World Health Organization). Within BioDoseNet initiative, the present web site has been developed and is managed by IRSN (Institut de Radioprotection et de Sûreté Nucléaire, France).